Xeris Biopharma Holdings, Inc. - Common Stock (NQ:XERS)
Price and Volume
Detailed Quote| Volume | 102 |
| Open | 5.440 |
| Bid (Size) | 5.380 (600) |
| Ask (Size) | 5.430 (200) |
| Prev. Close | 5.440 |
| Today's Range | 5.440 - 5.440 |
| 52wk Range | 3.805 - 10.08 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit
February 26, 2026
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗
December 31, 2025
The market is filled with gapping stocks in Wednesday's session. ↗
December 31, 2025
Xeris Biopharma (XERS) Q3 2025 Earnings Transcript ↗
November 06, 2025
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®
August 25, 2025
Xeris (XERS) Q2 Revenue Jumps 49% ↗
August 07, 2025
Frequently Asked Questions
Is Xeris Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Xeris Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Xeris Biopharma Holdings, Inc. - Common Stock trade on?
Xeris Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock is XERS on the Nasdaq Stock Market
What is the current price of Xeris Biopharma Holdings, Inc. - Common Stock?
The current price of Xeris Biopharma Holdings, Inc. - Common Stock is 5.440
When was Xeris Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Xeris Biopharma Holdings, Inc. - Common Stock was at 03/20/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.